Facebook
Twitter
Telegram
Report an ErrorKinnate Biopharma Financial Statements 2011-2024 | KNTE
Annual Financial Statements Kinnate Biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
124 M | 207 M | 339 M | 222 M | - | - | - | - | - | - | - | - | - |
Shares |
46.6 M | 44.1 M | 43.6 M | 6.77 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
2.66 | 4.69 | 7.78 | 33.4 | - | - | - | - | - | - | - | - | - |
Net Income |
-113 M | -116 M | -89.8 M | -35.8 M | -12 M | -7.63 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-121 M | -119 M | -90.1 M | -36 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 240 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-120 M | -118 M | -90 M | -35.9 M | -12 M | -7.63 M | - | - | - | - | - | - | - |
Operating Expenses |
121 M | 119 M | 90.1 M | 36 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
28.2 M | 30.4 M | 22.9 M | 6.76 M | 3.06 M | 1.96 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Kinnate Biopharma
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
47.1 M | 46.7 M | 45.4 M | 44.3 M | 44.2 M | 44 M | 43.9 M | 43.9 M | 43.7 M | 43.5 M | 43.5 M | 43.5 M | 3.75 M | 3.71 M | 3.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-30.7 M | -31.9 M | -32.9 M | - | -30.7 M | -27.1 M | -26.9 M | - | -24.7 M | -21.4 M | -17.5 M | - | -10.5 M | -7.61 M | -3.94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-33.1 M | -34.1 M | -34.7 M | - | -31.4 M | -27.4 M | -27.1 M | - | -24.8 M | -21.6 M | -17.5 M | - | -10.5 M | -7.63 M | -4.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | -540 K | -548 K | -379 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -34.4 M | - | -31 M | -27.2 M | -27 M | - | -24.7 M | -21.5 M | -17.4 M | - | -10.4 M | -7.59 M | -4.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
33.1 M | 34.1 M | 34.7 M | - | 31.4 M | 27.4 M | 27.1 M | - | 24.8 M | 21.6 M | 17.5 M | - | 10.5 M | 7.63 M | 4.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
6.6 M | 7.81 M | 8.09 M | - | 7.82 M | 7.64 M | 7.41 M | - | 6.07 M | 5.33 M | 4.82 M | - | 2.02 M | 2.05 M | 955 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency